| Term 
 
        | What is the typical location for Nicotinic neuronal receptor (Nn)? |  | Definition 
 
        | ganglionic neurons** (fast EPSP) adrenal medulla, some presynaptic cholinergic terminals, CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | Waht is the typical location for Nicotinic muscular receptors (Nm)? |  | Definition 
 
        | skeletal neuromuscular endplates |  | 
        |  | 
        
        | Term 
 
        | What is the typical location for the M1 receptor? |  | Definition 
 
        | Ganglionic neurons** (early slow EPSP) some presynaptic terminals, CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location for M2 receptors? |  | Definition 
 
        | Myocardium** (THINK 2 of HEARTs), presynaptic terminals**
 ganglionic neurons (IPSP),
 some smooth muscle,
 CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location for M3 receptors? |  | Definition 
 
        | Smooth muscle**, exocrine glands**, vascular endothelium**, CNS neurons |  | 
        |  | 
        
        | Term 
 
        | What is the main postreceptor mechanism of M1 receptor type? |  | Definition 
 
        | Gq protein, where there is an increase in phospholipase C which causes an increase in IP3/DAG system and there is a closing of K+ channels (note M3 has similar mechanism)
 |  | 
        |  | 
        
        | Term 
 
        | What is the main post receptor mechanism for M2 receptor type? |  | Definition 
 
        | Gi protein causes a decrease in cAMP and/or opening of K+ channels |  | 
        |  | 
        
        | Term 
 
        | What is the main post receptor mechanism for M3 receptor type? |  | Definition 
 
        | Gq protein, an increase in phospholipase C causing an increase in IP3/DAG system. |  | 
        |  | 
        
        | Term 
 
        | Monoamine oxidase (MAO) Where is it localized?
 substrate specificity?
 Isozymes?
 |  | Definition 
 
        | localized: in mitochondrial membrane of hepatic, kidney, and nueronal cells Has a low substrate specificity.
 Isozymes: Has two isozymes
 MAO-A: oxidates indolamines
 MAO-B: oxidates catecholamines (i.e. takes part in catecholamine metabolism after they are released into the synaptic cleft i.e. metabolizes NE, however this is not hte primary mechanism of postjunctional activity, the primary mechanism is reuptake into the cell)
 |  | 
        |  | 
        
        | Term 
 
        | Catechol-O-methyl-transferase (COMT) Where is it localized?
 What is the process of metabolism of epinephrine and norepinephrine?
 metabolism of Dopamine by COMT?
 |  | Definition 
 
        | Localized: in cytoplasm of most cells but is scarce in adrenergic neurons. metabolism of epi and norepi: when located intraneuronally, they are deaminated by MAO and then methylated by COMT, but: when extraneuronally located they are methylated by COMT and then deaminated by MAO yielding in both cases= vanillymandelic acid
 
 Dopamine metabolism: similar to epi and norepi with MAO and COMT yielding final metabolite of= homovanillic acid
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of Alpha 1 receptors? |  | Definition 
 
        | Vascular smooth muscle**(has primarily alpha 1 receptors) visceral smooth muscle(mainly sphincters)
 radial msucle of iris
 CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What are the typical locations of Alpha-2 receptors? |  | Definition 
 
        | Some presynaptic terminals** pancreatic islets (beta cells)
 platelettes
 ciliary epithelium
 smooth muscle
 CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What are the primary locations of beta-1 receptors? |  | Definition 
 
        | myocardium** JG cells**
 some presynaptic terminals
 adipocytes
 CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What are the typical locations of Beta-2 receptors? |  | Definition 
 
        | visceral smooth muscle** vascular smooth muscle**
 liver**
 myocardium
 skeletal muscle
 some presynaptic terminals
 CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of Beta-3 receptors? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the typical location for D-1 receptors? |  | Definition 
 
        | Vascular smooth muscle (renal and mesenteric vascular beds)** CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location for D-2 receptors? |  | Definition 
 
        | Some presynaptic terminals, CNS neurons
 |  | 
        |  | 
        
        | Term 
 
        | Which adrenergic receptors are coupeled to Gs protein and cause an increase in cAMP? |  | Definition 
 
        | Beta1 (also opens voltage gated CA++ channels (L type)) Beta2
 Beta3
 D1
 |  | 
        |  | 
        
        | Term 
 
        | What are the major (2) post receptor mechanisms for the Alpha-1 receptor which is coupled to Gqprotein? |  | Definition 
 
        | 1. increase in phospholipase C causing an increase in IP3/DAG (same as M1 and M3 receptors) 
 2. increase in phospholipase A2 causing an increase in eicosanoid synthesis
 |  | 
        |  | 
        
        | Term 
 
        | Describe the postreceptor mechanisms for Alpha 2 receptor  coupled to Gi and G0 protein? |  | Definition 
 
        | Gi: decrease in cAMP Gi: opening of ligand gated K+ channels
 G0: bloackade of voltage gated Ca2+ channels (Land N type)
 |  | 
        |  | 
        
        | Term 
 
        | Describe the postrceptor mechanisms for D-2 receptors coupled to Gi and Go proteins |  | Definition 
 
        | Gi: opening of ligand gated K+ channels Go: blockade of voltage gated Ca2+ channels
 |  | 
        |  | 
        
        | Term 
 
        | when does ACH have an inhibitory response? What receptor does it act on?
 What is the mechanism?
 |  | Definition 
 
        | When ACH activates M2 receptors This stimulates the release of dopamine or norepinephrine from small intensely fluorescent cells (SIF)
 Which causes the opening of ligand-gated K+ channels
 This leads to IPSP
 |  | 
        |  | 
        
        | Term 
 
        | what 6 receptors are involved in ganglionic neurotransmission? What neurotransmitter is involved?
 what is their AP type?
 |  | Definition 
 
        | 1. Nn-ACH-fast EPSP 2. M1-ACH-early slow EPSP (several seconds)
 3. Peptidergic-peptides-late slow EPSP (lasting several minutes)
 4. M2-ACH-IPSP
 5.D2-Dopamine-IPSP
 6. Alpha-2-NE-IPSP
 |  | 
        |  | 
        
        | Term 
 
        | In the periphery, most PNS target organs will have which receptor type? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS for the eye: give the response and recpetor for each: 1. sphincter of iris 2. ciliary muscle 3. lacrimal glands |  | Definition 
 
        | 1. sphincter of iris contracts-M3 2. Ciliary muscle: contraction -M3 3. Lacrimal glands-secretion-M3 |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effect on the eye: give the response and receptor 1. radial muscle of the iris 2. ciliary muscle 3. superior tarsal muscle 4. ciliary epithelium |  | Definition 
 
        | 1. radial muscle of iris: contraction/dilation of pupil- alpha1 2. ciliary muscle -relaxation-Beta 2 3. superior tarsal muscle - contraction-alpha1 4. ciliary epithelium: -increase aqueous humor production-beta2 -decrease aqueous humor production-alpha2 2. |  | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS effects on the lung:response and receptor 1. bronchial muscle 2. secretions |  | Definition 
 
        | 1.bronchial muscle: contraction: M3 2.secretions: increase:M3 |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS on the lung: effect and receptors? 1. bronchial muscle 2. secretions |  | Definition 
 
        | 1. bronchial muscle-relaxation- Beta2 2. secretions-decrease - alpha1 increase secretions-beta 2 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | no sympathetic outflow so no sweating |  | 
        |  | 
        
        | Term 
 
        | the neurotransmitter of the postganglionic sympathetic nerve for sweating is what? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In skin,(adrenergic/SNS) what type of effect and which receptor type are used for  1. pilomotor muscles (goosebumbs) 2. apocrine sweat glands |  | Definition 
 
        | 1. pilomotor muscles-contraction-alpha 1 receptors 2. apocrine sweat glands-secretion- alpha 1 receptors |  | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS effects on skin sweat gland ? receptor type? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Effects of cholinergic/PNS on GI tract and receptors: 1. motility and tone 2. lower esophageal sphincter 3. other sphincters 4. glands (salivary, gastric, etc..) |  | Definition 
 
        | 1. motility and tone will increase -M3 2.Lower esophageal sphincter-contract-M3 3. other sphincters-relaxation-indirect effect 4. glands-watery secretion-M3 |  | 
        |  | 
        
        | Term 
 
        | Effects on cholinergic/PNS gallbaladder and ducts, receptor?  Effects of adrenergic/SNS on gall bladder, ducts and receptor? |  | Definition 
 
        | cholinergic/PNS: contraction-M3 adrenergic/SNS: relaxation Beta 2 |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effects on the GI and receptors: 1. glands 2. motility and tone 3. spchincters |  | Definition 
 
        | 1. thick secretion Beta receptors 2. motility and tone - relaxed- alpha1, alpha2, beta2 3. sphincters-contraction-alpha 1 |  | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS effects on the pacreas and receptors? 1. exocrine secretion 2. insulin secretion |  | Definition 
 
        | 1. exocrine secretion-increases M3 2. insuline secretion-increases M receptors |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effects on pancreas and receptors? 1. exocrine secretion 2. insulin secretion 3.glucagon secretion |  | Definition 
 
        | 1. exocrine secretion decrease-alpha 2. insulin secretion decrease- alpha 2 (increase insulin with beta2) 3. glucagon secretion increase Beta |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effect on liver and receptors? |  | Definition 
 
        | increase glycogenolysis (B2>>A1) increase gluconeogensis (B2>>A1)   PNS doesnt have any significant effect on the liver |  | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS effects on sex organs and receptors 1. corpora cavernosa 2. uterus |  | Definition 
 
        | 1. corpora cavernosa-erection-M3 via NO 2. uterus- variable effect- M3 |  | 
        |  | 
        
        | Term 
 
        | cholinergic/SNS effect on sex organs and receptors? 1. vas deferens, seminal vesicle prostate 2. non pregnant uterus 3. pregnant uterus |  | Definition 
 
        | 1. ejaculation - alpha1 2. non pregnant uterus- relaxation -beta 2 3. pregnant uterus- relaxation beta2 contraction-alpha1 |  | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS effect on urinary bladder and receptors? 1. detrusor (motility and tone) 2. trigone and sphincter |  | Definition 
 
        | 1. detrusor -increase motility and tone-M3 2. trigone and sphincter relaxation-indirect effects |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS on kidney and receptors? |  | Definition 
 
        | increases renin secretion -beta 1  (remember beta 1 are only in heart and JG cells of kidney) |  | 
        |  | 
        
        | Term 
 
        | What is the dominant ans system for blood vessels? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | cholinergic/PNS on arerioles and receptor? |  | Definition 
 
        | dilation - M3 via NO  (pns has negligible effects on veins) |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effects on arterioles  and receptors? 1. various organs 2. coronary, pulmonary 3. skeletal muscle 4. liver |  | Definition 
 
        | 1. various organs-constriction-alpha 1 2. coronary, pumonary -dilation-indirect effects 3. skeletal muscle-dilation-beta 2 4. liver- dilation -beta 2 |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effects on veins and their receptors? |  | Definition 
 
        | constriction- alpha1 dilation-beta 2  remember that PNS has negligible effects on veins, so it is predominantly controlled by SNS |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS effect on spleen capsule and receptor? |  | Definition 
 
        | spleen capsule contraction by Alpha1 |  | 
        |  | 
        
        | Term 
 
        | adrenergic/SNS on the heart and the accompanying receptors? 
 1. Heart: SA node rhythm 2. Atrium a. conduction b. refractoriness c. automaticty d. contractility 3. AV node a. conduction b. refractoriness c. automaticity 4. ventricle a. conduction b. refractoriness c. automaticity d. contractility |  | Definition 
 
        | remember: for all responses of SNS B1 is better than B2 (B1>>B2)     1. Heart: SA node rhythm increases : B1 2. Atrium a. conduction: increases B1 b. refractoriness: decreases B1 c. automaticty increases B1 d. contractility increases B1 3. AV node increases B1 a. conduction increases B1 b. refractoriness decreases B1 c. automaticity increases B1 4. ventricle increases B1 a. conduction increases B1 b. refractoriness decreases B1 c. automaticity increases B1 d. contractility increases B1   |  | 
        |  | 
        
        | Term 
 
        |   
cholinergic/PNS on the heart and the accompanying receptors? 
 1. Heart: SA node rhythm 2. Atrium a. conduction b. refractoriness c. automaticty d. contractility 3. AV node a. conduction b. refractoriness c. automaticity 4. ventricle a. conduction b. refractoriness c. automaticity d. contractility   |  | Definition 
 
        |   1. Heart: SA node rhythm decreases: M2   2. Atrium a. conduction increase M2 b. refractoriness decrease M2 c. automaticty decrease then increase M2 d. contractility decrease M2   3. AV node a. conduction decrease M2 b. refractoriness increase M2 c. automaticity decrease M2   4. ventricle (only effects on contractility) a. conduction nothing  b. refractoriness nothing c. automaticity nothing d. contractility decrease M2   |  | 
        |  | 
        
        | Term 
 
        | ACH has inhibitory effects on which receptor? and which neuron terminals? |  | Definition 
 
        | receptor M2 neuron terminals: adrenergic and cholinergic |  | 
        |  | 
        
        | Term 
 
        | Norepinephrine has inhibitor effects on which receptor and which nueron terminals? |  | Definition 
 
        | receptor: alpha 2 neuron terminals: adrenergic and cholinergic |  | 
        |  | 
        
        | Term 
 
        | Norepinephrine has inhibitor effects on which receptor and which nueron terminals? |  | Definition 
 
        | receptor: alpha 2 neuron terminals: adrenergic and cholinergic
 |  | 
        |  | 
        
        | Term 
 
        | epinephrine has excitatory effects on which receptor and which neuron terminals? |  | Definition 
 
        | beta 2 receptors for adrenergic and somatic motor cholinergic neuron terminals. |  | 
        |  | 
        
        | Term 
 
        | what are three mechanisms for indirect adrenergic drugs? |  | Definition 
 
        | 1. facilitated exchange diffusion 2. false transmitter concept
 3. inhibition of reuptake of catecholamines that are already released
 |  | 
        |  | 
        
        | Term 
 
        | effects of SNS on fat cells and the accompanying receptors? |  | Definition 
 
        | increased lipolysis Beta 3 decreased lipolysis alpha 2
 |  | 
        |  | 
        
        | Term 
 
        | effects of SNS on platelets  and the accompanying receptor? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effect of SNS on mast cells, basophils and the accompanying receptor? |  | Definition 
 
        | inhibition of granulation -Beta 2 |  | 
        |  |